Abstract
Deferoxamine (DFO) was administered during the first 2 hours of hemodialysis and aluminum (Al) kinetics was studied during the next dialysis in 24 hemodialysis patients. After DFO administration, plasma Al and ultrafiltrable fraction of plasma Al increased significantly, and a reduction of 37.4 % in plasma Al after dialysis was obtained. The results demonstrated that DFO administered at the beginning of dialysis was effective in enhancement of Al removal during the subsequent dialysis. In the treatment of Al intoxication in hemodialysis patients, an administration of DFO at the beginning of every other dialysis is recommended.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
